Your browser doesn't support javascript.
loading
MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.
Seferoglu, Meral; Ethemoglu, Özlem; Turan, Ömer Faruk; Siva, Aksel.
Affiliation
  • Seferoglu M; Department of Neurology, Bursa Yüksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa, Turkey. meralbozseferoglu@gmail.com.
  • Ethemoglu Ö; Department of Neurology, Harran University School of Medicine, Sanliurfa, Turkey.
  • Turan ÖF; Department of Neurology, Uludag University School of Medicine, Bursa, Turkey.
  • Siva A; Department of Neurology and MS Clinic, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Neurol Sci ; 42(9): 3533-3535, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34165650
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / COVID-19 / Multiple Sclerosis Limits: Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Turkey Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / COVID-19 / Multiple Sclerosis Limits: Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Turkey Country of publication: Italy